Submissions

Author Guidelines

The editors of JIVR welcome the submission of manuscripts devoted to all types of research in Injury and Violence fields.

Each manuscript is considered for publication with the following understandings:

A. Authorship:

1) All persons designated as authors should qualify for authorship. The order of authorship should be a joint decision of the co-authors. Each author should have participated sufficiently in the work to take public responsibility for the content. Authorship credit should be based only on a substantial contribution to (a) conception and design, or analysis and interpretation of data; and to (b) drafting the article or resizing it critically for important intellectual content; and on (c) final approval of the version to be published. Conditions (a), (b), and (c) must all be met. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.

2) Ghostwriting: It is unacceptable for a person who lends the use of his or her name to a manuscript (whether or not a fee has been paid for the use of that name), when the manuscript has been written by another person/persons who do not identify themselves, their affiliation, or potential or real conflicts of interest. Therefore, ghostwritten articles will be immediately rejected.

3) None of the material in the manuscript has been published previously nor is any of the material currently under consideration for publication elsewhere (including tables, illustrations, etc.) in any other journal.

If a manuscript is accepted for publication, the author(s) will be asked to assign the copyright to the publisher.

B. MANUSCRIPTS

1. Submission: The following link: http://jivresearch.org/jivr/index.php/jivr/author/submit/1 is for authors to submit their manuscript/s and any other artworks as usable electronic files. In cover letter, authors should state that the manuscript, or parts of it, have not been and will not be submitted elsewhere for publication.

Notice: In the " Confirmation" at the end of the registration page, in the " Register as "  section, please don't forget to choose "  Author: Able to submit items to the journal". If you forget to choose this section, you will not be permitted to submit your manuscript.   

Solution: If you find this problem, please go to the "Edit My Profile" in the "User Home", or simply just click on this link: (http://jivresearch.org/jivr/index.php/jivr/user/profile) and at the end of the page in the "Roles" section, please select: "Author". 

Submission items include a cover letter, suggested reviewers (if any), the manuscript file (including a title page; the ab­stract; introduction; methods; results; discussion; ac­knowl­edge­ments, declarations, ref­erences and table/figure legends (as one MS Word (.doc, docx) file). If authors have submitted and are asked to revise manuscripts, they also will be asked to include a unique file with responses to reviewers' comments.

File formats: Please use MS Word for the text files. Graphics should be saved as TIFF, or JPG, in MS Word (.doc, .docx).

Please Do not send your text as a PDF. 

Authors who are unable to provide an electronic version or have other circumstances that prevent sending by e-mail must contact the Editorial Office before submission to discuss alternate options. 

2. The manuscript should include: title page; the ab­stract; introduction; methods; results; discussion; ac­knowl­edge­ments, declarations and ref­erences. 

3. The title page: The complete title of the manuscript, the name of all the authors with their E-mail, highest qualifications, the department or institution to which they are attached, and address for correspondence with telephone numbers, e-mail, and Fax number. Please provide a running title of up to 50 characters. 

4. The Abstract: All original articles must accompany a structured abstract of up to 300 words. It should be structured as Background, Methods, Results, and Conclusions followed by 3 to 5 Keywords. Keywords will assist indexers in cross-indexing the article as they are published with abstracts. Use terms from the Medical Subject Headings (MeSH) list of index medicus (http://www.nlm.nih.gov/mesh/MBrowser.html ).  Authors need to be careful that the abstract reflects the content of the article accurately. Except for letters to the editor, grand rounds, book reviews and editorials, all other types of publications require a brief, standard abstract of a few sentences. Do not cite references or use abbreviations in the structured (or other) abstract. 

5. Introduction: This should summarize the purpose and the rationale for the study. It should neither review the subject extensively nor should it have data or conclusions of the study. 

6. Methods: A clear and precise description of the experiment and the subjects from whom the data were derived. If subjects were randomized, describe the methods of randomization used. Identify all drugs and chemicals used, dosages, and routes of administration. Define all statistical methods used. 

7. Results: A factual account of the study's findings. Present these as logically appropriate in text, tables, or illustrations; do not repeat in the text what is demonstrated in a table or illustration. 

8. Discussion: A summary emphasizing new and important aspects of the study's conclusions. Ensure that all conclusions are justified by the results of the study. Identify the implications of the findings and their limitations, including implications for future research. Look at the pros and cons of the methods and results. Compare the implications and limitations of these findings with those reported in other essential studies. State new hypotheses when warranted, but clearly label them as such. Recommendations, where appropriate, may be included. 

9. Acknowledgements: All authors should have made substantial contributions to all of the following: (1) The conception and design of the study, or acquisition of data, or analysis and interpretation of data; (2) Drafting the article or revising it critically for important intellectual content; and (3) Final approval of the version to be submitted.
All contributors who do not meet the criteria for authorship as defined above should be listed in the "Acknowledgements" section. Examples of those who might be acknowledged include a person who provided purely technical help, or writing assistance, or a department chair who provided only general support. 

10. Declarations: Upon submission, authors will be required to declare funding, and competing interests and to indicate whether ethical approval was sought. This information must also be inserted into the manuscript under the "Acknowledgements" section with the headings below. If there are no declarations to make, the following statements should be inserted into the manuscript:

Funding: None
Competing interests: None declared
Ethical approval: Not required

Competing interests: All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work under the "Competing interests" statement. Examples of potential competing interests include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding.

Funding: All sources of funding should be declared. Authors should declare the role of study sponsors, if any, in the study design; in the collection, analysis and interpretation of data; in the writing of the manuscript; and in the decision to submit the manuscript for publication. If the study sponsors had no such involvement, the authors should so state. 

Ethical approval: Work on human beings that is submitted to Journal of Injury and Violence Research should comply with the principles laid down in the Declaration of Helsinki; Recommendations guiding physicians in biomedical research involving human subjects. Adopted by the 18th World Medical Assembly, Helsinki, Finland, June 1964, amended by the 29th World Medical Assembly, Tokyo, Japan, October 1975, the 35th World Medical Assembly, Venice, Italy, October 1983, and the 41st World Medical Assembly, Hong Kong, September 1989. The manuscript should contain a statement that the work has been approved by the appropriate ethical committees related to the institution(s) in which it was performed and that subjects gave informed consent to the work. Studies involving experiments with animals must state that their care was in accordance with institutional guidelines.

11. References: References must be publicly available and verified by the authors and against the original documents. Number references sequentially in the order of their citation in the manuscript. For each citation, include all names unless the authors' number six or more; in that case, list six names followed by "et al." Do not use periods after authors' initials. Provide inclusive page numbers for journal articles and specific page citations for books. Identify abstracts and letters. Style references according to "International Committee of Medical Journal Editors: Uniform requirements for manuscripts submitted to biomedical journals." N Engl J Med 1997; 336:309-15. 

Examples of correct forms of references for numerical style

Article in journal:

1. Ahmadi A, Mohammadi R, Schwebel DC, Hassanzadeh M, Yari M.Classic philosophy lessons and preventing self-inflicted burns: a call for action. 2009;35(1):154-5.            

 Book:

2. Thompson T, Kanton B. Hormonal and metabolic considerations in the acutely ill patient, 2nd ed. New York: Timely Publications, 1987:25-125,209-301. 

 Edited volume:

3. Nye JS,  Zelikow PD, King DC. Why People Don't Trust Government. Cambridge, MA: Harvard University Press, 1997.

 Chapter in book:

4. Baldwin T. Effective infusion therapy. In: Pronter K, Baldwin T, Senthoff V (eds): Insulin Infusion System Delivery. Baltimore: Immediate Press Publishers, 1986:88-152.

 Article in newspaper:

5. Webster B. Record bonus for Network Rail chief, despite Christmas chaos. The Times 2008,6 June:1-3.

 Newspaper or magazine article (without a named author):

6. Economist.The mountain man and the surgeon. 2005, 24 December:24-26.

 Article online:

7. Gardener T, Moffatt J. Changing behaviors in defence acquisition: a game theory approach. Journal of the Operational Research Society, advance online publication 2007, 28 November, doi: 10.1057/palgrave.jors.2602476. 

Other online resource:

8. Green Party. Greens call for attack on asylum "push factors". Green Party report 2005, 4 March, http://www.greenparty.org.uk/index.php?nav=new&n=1838, accessed 9 March 2005. 

Conference proceedings:

9. Sapin A. Health and the Environment. Proceedings of the Conference on Biological Monitoring Methods for Industrial Chemicals; 30 31 March 1984, Chicago, IL. Chicago: American Toxological Association. 

Conference paper:

10. Harley NH. Radon risk models. In: A.R. Knight and B. Harrad, (eds.) Indoor Air and Human Health. Proceedings of the Seventh Life Sciences Symposium; 29-31 October, Knoxville, TN. Amsterdam: Elsevier, 1981:69-78. 

Papers/talks presented at a conference but not published:

11. Martin S.  An exploration of factors that have an impact on the vocal performance and vocal effectiveness of newly qualified teachers and lecturers. Paper presented at the Pan European Voice Conference; 31 August, Graz, Austria, 2003. 

Dissertation/thesis:

12. Young WR. Effects of different tree species on soil properties in central New York. MSc thesis, Cornell University, Ithaca, NY, 1981.

Research papers/reports/working papers 

13. Bloom G. et al . Poverty Reduction During Democratic Transition: The Malawi Social Action Fund 1996-2001. Brighton, UK: Institute of Development Studies. IDS Research Report no. 56, 2005. 

Mimeo:

14. Bond SA, Hwang S, Lin Z, Vandell K. Marketing Period Risk in a Portfolio Context: Theory and Empirical Estimates from the UK Commercial Real Estate Market. Cambridge, UK: Department of Land Economy, University of Cambridge (mimeo), 2005. 

Speech:

15. Blair A. Britain in the World. Speech to FCO Leadership Conference. London, 2003, 7 January.

12. Tables: In limited numbers should be submitted with the captions placed above. Do not submit tables as pho­tograph. Place explanatory matters in footnotes, not in the heading. 

13. Figures:  Should be in limited numbers, with high-quality art work, and mounted on separate pages. The cap­tions should be placed below. The same data should not be presented in tables, fig­ures, and text, simultane­ously.

Image File Requirement: See preferred files specification: http://www.ncbi.nlm.nih.gov/pmc/about/image_quality_ table.html

 14. Proof Reading: Computers print out is sent to the corresponding author for proof reading before publication in order to avoid any mistakes. Corrections should be marked clearly and sent immediately to the Journal office.

 15. Abbreviations and symbols: Use only standard abbre­viations. Avoid using them in the title and abstract. The full term for which an abbreviation stands should precede its first use in the text unless it is a standard unit of measurement.

 16. Page charges:  There are no charges for publica­tion in this Journal.

 17. Copyright: Published articles in this journal are open-access articles distributed under the terms of the Creative Commons Attribution 3.0 License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

 18. Peer review process: All manuscripts are considered to be confidential. They are peer-reviewed by at least 2 anonymous reviewers selected by the Editor.  The corresponding author is notified as soon as possible of the editor's decision to accept, reject, or require modifications. If the manuscript is completely acceptable according to the criteria outlined in these instructions, it is scheduled for the next available issue.

 19. Randomized controlled trials:  

All randomized controlled trials submitted for publication in the Journal of Injury and Violence Research should include a completed Consolidated Standards of Reporting Trials (CONSORT) flow chart. Please refer to the CONSORT statement website at http://www.consort-statement.org for more information.

Further information can be found at www.icmje.org.

 20. Permissions and Credits: Illustrations, tables, or lengthy quotations from published sources must be acknowledged with a full bibliographic citation. The author's and publisher's permission to reprint must be submitted as soon as the manuscript is accepted for publication. One copy of any article not accepted for publication will be kept by the JIVR in its files for six months.

 21. Drug and Chemical Names: Refer to drugs by their approved generic names. If trade names are used, the generic equivalent should be given parenthetically at first use. Identify compounds by their formal chemical name at first use; after that the trivial name may be used.

---------------------------------------------

Prior and Repetitive Publication / Plagiarism

Journal of Injury and Violence will not consider the manuscripts if:
• large pieces of text have been cut-and-pasted without appropriate referencing and citation;
• paraphrasing and summarizing the others' work have not been appropriately attributed;
• duplicate publication or self-plagiarism occurs.
To avoid any unintended plagiarism and violence in copyrighting, please use plagiarism checker software tools to screen your manuscript before submission.

Additionally, the Journal of Injury and Violence Research routinely screens article submissions by a well-accepted plagiarism detection software called "iThenticate".

---------------------------------------

Archiving Policy:

The journal's content access is preserved through PubMedCentral at: https://www.ncbi.nlm.nih.gov/pmc/journals/1484/

-------------------------------------

Repository Policy:

The Journal of Injury and Violence Research permits authors to deposit all versions of their work in an institutional or other repository of their choice, without any imposed embargo.

------------------------------------

***NOTE***: Please enter your ORCID ID and URL following the below path:

Metadata page > Submission and Publication Metadata > List of Contributors > Add Contributors > URL & ORCID. " ORCID ID should be followed by: http and URL by https "

The below samples are provided as guidelines for your consideration:

ORCID ID: http://orcid.org/0000-0002-6058-0322
URL: https://orcid.org/0000-0002-6058-0322

 Additional Information:

The Journal's editor-in-chief is Mahmoudreza Moradi, MD (jivr1@jivresearch.org)

Direct questions to the editorial office at:

jivr1@jivresearch.org